Corporate$WAT8:00 AM ET

Waters and Labcorp to expand cervical cancer screening access with HPV testing in late 2026

By BORSA NewsroomPublished Oct 23, 2026, 8:00 AM EDTUpdated Oct 23, 2026, 8:06 AM EDT

Waters and Labcorp will expand access to cervical cancer screening using an FDA-approved HPV testing option.

Sentimentbullish 70

Bullish · 70 of 100

Impact40

low · stays off the top drivers

Confidence90%

high confidence · single wire

Eventdeveloping

v1 · alerted to followers

WHAT WE KNOW

Waters, Labcorp to Expand Access to Cervical Cancer Screening With Most Comprehensive FDA-Approved HPV Testing Option Beginning in Late 2026